# Endoscopic Ultrasound-guided Ethanol Injection of Pancreatic Cystic Neoplasms

> **NCT02158039** · PHASE1 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 33 (actual)

## Conditions studied

- Neoplasms, Cystic, Mucinous, and Serous

## Interventions

- **DRUG:** Ethanol
- **DRUG:** Lidocaine

## Key facts

- **NCT ID:** NCT02158039
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06
- **Primary completion:** 2015-09
- **Final completion:** 2015-09
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2018-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02158039

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02158039, "Endoscopic Ultrasound-guided Ethanol Injection of Pancreatic Cystic Neoplasms". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT02158039. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*